NCT05676112View on ClinicalTrials.gov

Safety of Nintedanib in Real World in China

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

December 29, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Pulmonary Fibrosis
Interventions
DRUG

nintedanib

nintedanib

DRUG

pirfenidone

pirfenidone

Sponsors
All Listed Sponsors
collaborator

China-Japan Friendship Hospital

OTHER

lead

Boehringer Ingelheim

INDUSTRY

NCT05676112 - Safety of Nintedanib in Real World in China | Biotech Hunter | Biotech Hunter